// App-Quantinova.ai

P224 : A matching-adjusted indirect comparison (MAIC) of upadacitinib versus tofacitinib in csDMARD-IR patients with moderate to severe RA

Researchers

Presenter

  • Christopher Edwards

Principal Investigators

  • Ruta Sawant

  • Ella X Du

  • Jordan Cammarota

  • Patrick Tang

  • Vishvas Garg

  • Alan Friedman

  • Keith Betts

Medical Centers

  • Faculty of Medicine, University of Southampton, Southampton, United Kingdom

  • AbbVie Inc, Waukegan Road, North Chicago, IL

  • Analysis Group, Inc., Los Angeles, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • C reactive protein

  • Plasminogen Activator, Urokinase

Drug/Treatment

  • Methotrexate

  • ABT-494

  • Tasocitinib

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved